HuGE Literature Finder
|
||
Records 1-93
|
Relationship between efficacy of sunitinib and KIT mutation of patients with advanced gastrointestinal stromal tumors after failure of imatinib: A systematic review.
Medicine 2019 May 98 (19): e15478. Xie Fuming, Xiao Weidong, Jiang Yahui, Xia Xiao, Wang Ya |
|
Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinib.
European journal of cancer (Oxford, England : 1990) 2017 Oct 86 226-232. Verboom Michiel C, Kloth Jacqueline S L, Swen Jesse J, van der Straaten Tahar, Bovée Judith V M G, Sleijfer Stefan, Reyners Anna K L, Mathijssen Ron H J, Guchelaar Henk-Jan, Steeghs Neeltje, Gelderblom Ha |
|
Early outcomes of exon 11 mutants in GIST treated with standard dose Imatinib.
Annals of translational medicine 2017 Mar 5 (6): 134. Ramaswamy Anant, Bal Munita, Swami Rohit, Shetty Omshree, Bose Subhadeep, Pai Trupti, Gurav Mamta, Gupta Sudeep, Ostwal Vik |
|
Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.
JAMA oncology 2017 Mar . Joensuu Heikki, Wardelmann Eva, Sihto Harri, Eriksson Mikael, Sundby Hall Kirsten, Reichardt Annette, Hartmann Jörg T, Pink Daniel, Cameron Silke, Hohenberger Peter, Al-Batran Salah-Eddin, Schlemmer Marcus, Bauer Sebastian, Nilsson Bengt, Kallio Raija, Junnila Jouni, Vehtari Aki, Reichardt Pet |
|
Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wildtype GISTs are rare events.
Human pathology 2017 Jan . Huss Sebastian, Pasternack Hlen, Ihle Michaela Angelika, Merkelbach-Bruse Sabine, Heitkötter Birthe, Hartmann Wolfgang, Trautmann Marcel, Gevensleben Heidrun, Büttner Reinhard, Schildhaus Hans-Ulrich, Wardelmann E |
|
Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors.
American journal of clinical pathology 2016 Dec . Merten Larissa, Agaimy Abbas, Moskalev Evgeny A, Giedl Johannes, Kayser Claudia, Geddert Helene, Schaefer Inga-Marie, Cameron Silke, Werner Martin, Ströbel Philip, Hartmann Arndt, Haller Flori |
|
Prognostic significance of KIT exon 11 deletion mutation in intermediate-risk gastrointestinal stromal tumor.
Asia-Pacific journal of clinical oncology 2016 Oct . Quek Richard, Farid Mohamad, Kanjanapan Yada, Lim Cindy, Tan Iain Beehuat, Kesavan Sittampalam, Lim Tony Kiat Hon, Oon Lynette Lin-Ean, Goh Brian Kp, Chan Weng Hoong, Teo Melissa, Chung Alexander Yf, Ong Hock Soo, Wong Wai Keong, Tan Patrick, Yip Desmo |
|
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2016 Jul . Ben-Ami E, Barysauskas C M, von Mehren M, Heinrich M C, Corless C L, Butrynski J E, Morgan J A, Wagner A J, Choy E, Yap J T, Van den Abbeele A D, Solomon S M, Fletcher J A, Demetri G D, George |
|
Transcriptomic reappraisal identifies MGLL overexpression as an unfavorable prognosticator in primary gastrointestinal stromal tumors.
Oncotarget 2016 Jun . Li Chien-Feng, Chuang I-Chieh, Liu Ting-Ting, Chen Ko-Chin, Chen Yen-Yang, Fang Fu-Min, Li Shau-Hsuan, Chen Tzu-Ju, Yu Shih-Chen, Lan Jui, Huang Hsuan-Yi |
|
Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2016 May . Capelli L, Petracci E, Quagliuolo V, Saragoni L, Colombo P, Morgagni P, Calistri D, Tomezzoli A, Di Cosmo M, Roviello F, Vindigni C, Coniglio A, Villanacci V, Catarci M, Coppola L, Alfieri S, Ricci R, Capella C, Rausei S, Gulino D, Amadori D, Ulivi P, |
|
Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom 2-gene targeted next-generation sequencing panel with therapeutic intent.
Gastrointestinal endoscopy 2016 Apr . Gleeson Ferga C, Kerr Sarah E, Kipp Benjamin R, Voss Jesse S, Minot Douglas M, Tu Zheng Jin, Henry Michael R, Vasmatzis George, Cheville John C, Lazaridis Konstantinos N, Levy Michael |
|
[Characteristics of Clinicopathology and Genotype in 179 Cases with Gastrointestinal Stromal Tumor].
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 2016 Mar 47 (2): 275-8, 282. Chen Jia-ju, Shen Chao-yong, Chen Hui-jiao, Yin Yuan, Tang Su-min, Zhang Bo, Chen Zhi-x |
|
Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors.
Oncotarget 2016 Feb . Gao Jing, Li Jian, Li Yanyan, Li Zhongwu, Gong Jifang, Wu Jian, Liu Na, Dong Bin, Qi Changsong, Li Jie, Shen L |
|
Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial.
BMC cancer 2016 16 (1): 22. Reichardt Peter, Demetri George D, Gelderblom Hans, Rutkowski Piotr, Im Seock-Ah, Gupta Sudeep, Kang Yoon-Koo, Schöffski Patrick, Schuette Jochen, Soulières Denis, Blay Jean-Yves, Goldstein David, Fly Kolette, Huang Xin, Corsaro Massimo, Lechuga Maria Jose, Martini Jean-Francois, Heinrich Michael |
|
PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1.
Oncology research 2016 24 (1): 41-53. Baskin Yasemin, Kocal Gizem Calibasi, Kucukzeybek Betul Bolat, Akbarpour Mahdi, Kayacik Nurcin, Sagol Ozgul, Ellidokuz Hulya, Oztop Ilh |
|
Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group.
European journal of cancer (Oxford, England : 1990) 2015 Dec 52 173-180. Patrikidou Anna, Domont Julien, Chabaud Sylvie, Ray-Coquard Isabelle, Coindre Jean-Michel, Bui-Nguyen Binh, Adenis Antoine, Rios Maria, Bertucci François, Duffaud Florence, Chevreau Christine, Cupissol Didier, Pérol David, Emile Jean-François, Blay Jean-Yves, Le Cesne Axel, |
|
Analysis of mutation of the c-Kit gene and PDGFRA in gastrointestinal stromal tumors.
Experimental and therapeutic medicine 2015 Sep 10 (3): 1045-1051. Xu Chun-Wei, Lin Shan, Wang Wu-Long, Gao Wen-Bin, Lv Jin-Yan, Gao Jing-Shan, Zhang Li-Ying, Li Yang, Wang Lin, Zhang Yu-Ping, Tian Yu-Wa |
|
KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study.
The American journal of surgical pathology 2015 Jul 39 (7): 922-30. Rossi Sabrina, Gasparotto Daniela, Miceli Rosalba, Toffolatti Luisa, Gallina Giovanna, Scaramel Enrico, Marzotto Alessandra, Boscato Elena, Messerini Luca, Bearzi Italo, Mazzoleni Guido, Capella Carlo, Arrigoni Gianluigi, Sonzogni Aurelio, Sidoni Angelo, Mariani Luigi, Amore Paola, Gronchi Alessandro, Casali Paolo G, Maestro Roberta, Dei Tos Angelo |
|
Efficacy of Imatinib in Patients with Platelet-derived Growth Factor Receptor Alpha-mutated Gastrointestinal Stromal Tumors.
Cancer research and treatment : official journal of Korean Cancer Association 2015 Jun . Yoo Changhoon, Ryu Min-Hee, Jo Jungmin, Park Inkeun, Ryoo Baek-Yeol, Kang Yoon-K |
|
[Application of gene mutation detection in gastrointestinal stromal tumors].
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2015 Apr 18 (4): 305-8. Hou Yachao, Deng Jingyu, Liang H |
|
[Mutation profiles of c-kit/PDGFR? and its associations with clinicopathological characteristics in Chinese gastrointestinal stromal tumors: analysis of 827 cases].
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2015 Apr 18 (4): 332-7. Li Yanyan, Gao Jing, Tian Ye, Li Jian, Shen L |
|
KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Feb 33 (6): 634-42. Joensuu Heikki, Rutkowski Piotr, Nishida Toshirou, Steigen Sonja E, Brabec Peter, Plank Lukas, Nilsson Bengt, Braconi Chiara, Bordoni Andrea, Magnusson Magnus K, Sufliarsky Jozef, Federico Massimo, Jonasson Jon G, Hostein Isabelle, Bringuier Pierre-Paul, Emile Jean-Franco |
|
Mutational profile of KIT and PDGFRA genes in gastrointestinal stromal tumors in Peruvian samples.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2015 Feb 107 (2): 72-8. Buleje José, Acosta Óscar, Guevara-Fujita María, Enriquez Yanina, Taxa Luis, Machicado Enrique, Lizaraso-Caparó Frank, Fujita Ricar |
|
Kinase genotype analysis of gastric gastrointestinal stromal tumor cytology samples using targeted next-generation sequencing.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2015 Jan 13 (1): 202-6. Gleeson Ferga C, Kipp Benjamin R, Kerr Sarah E, Voss Jesse S, Graham Rondell P, Campion Michael B, Minot Douglas M, Tu Zheng J, Klee Eric W, Lazaridis Konstantinos N, Henry Michael R, Levy Michael |
|
Molecular spectrum of c-KIT and PDGFRA gene mutations in gastro intestinal stromal tumor: determination of frequency, distribution pattern and identification of novel mutations in Indian patients.
Medical oncology (Northwood, London, England) 2015 Jan 32 (1): 424. Ahmad Firoz, Lad Purnima, Bhatia Simi, Das Bibhu Ranj |
|
Clinicopathological significance of c-KIT mutation in gastrointestinal stromal tumors: a systematic review and meta-analysis.
Scientific reports 2015 5 13718. Yan Lin, Zou Lei, Zhao Wenhua, Wang Yansen, Liu Bo, Yao Hongliang, Yu Haih |
|
Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study.
World journal of surgical oncology 2015 13 47. Rubió-Casadevall Jordi, Borràs Joan Lluis, Carmona-García Maria Carme, Ameijide Alberto, Gonzalez-Vidal Allan, Ortiz Maria Rosa, Bosch Ramon, Riu Francesc, Parada David, Martí Esther, Miró Josefina, Sirvent Juan Jose, Galceran Jaume, Marcos-Gragera Rafa |
|
Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a european multicenter analysis based on ConticaGIST.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Dec 20 (23): 6105-16. Wozniak Agnieszka, Rutkowski Piotr, Schöffski Patrick, Ray-Coquard Isabelle, Hostein Isabelle, Schildhaus Hans-Ulrich, Le Cesne Axel, Bylina Elzbieta, Limon Janusz, Blay Jean-Yves, Siedlecki Janusz A, Wardelmann Eva, Sciot Raf, Coindre Jean-Michel, Debiec-Rychter Mar |
|
The outcome of targeted therapy in advanced gastrointestinal stromal tumors (GIST) with non-exon 11 KIT mutations.
Polski przeglad chirurgiczny 2014 Jul 86 (7): 325-32. Osuch Czes?aw, Rutkowski Piotr, Brzuszkiewicz Karolina, Bylina El?bieta, Limon Janusz, Siedlecki Janusz |
|
Prognostic value of mutational characteristics in gastrointestinal stromal tumors: a single-center experience in 275 cases.
Medical oncology (Northwood, London, England) 2014 Jan 31 (1): 819. Wang Ming, Xu Jia, Zhao Wenyi, Tu Lin, Qiu Weiqing, Wang Chaojie, Shen Yangyin, Liu Qiang, Cao H |
|
C-kit and PDGFRA gene mutations in triple negative breast cancer.
International journal of clinical and experimental pathology 2014 7 (7): 4280-5. Zhu Yun, Wang Yan, Guan Bing, Rao Qiu, Wang Jiandong, Ma Henghui, Zhang Zhihong, Zhou Xiaoj |
|
Frequent KIT mutations in human gastrointestinal stromal tumors.
Scientific reports 2014 4 5907. Xu Zhi, Huo Xinying, Tang Chuanning, Ye Hua, Nandakumar Vijayalakshmi, Lou Feng, Zhang Dandan, Jiang Shouwen, Sun Hong, Dong Haichao, Zhang Guangchun, Liu Zhiyuan, Dong Zhishou, Guo Baishuai, Yan He, Yan Chaowei, Wang Lu, Su Ziyi, Li Yangyang, Gu Dongying, Zhang Xiaojing, Wu Xiaomin, Wei Xiaowei, Hong Lingzhi, Zhang Yangmei, Yang Jinsong, Gong Yonglin, Tang Cuiju, Jones Lindsey, Huang Xue F, Chen Si-Yi, Chen Jinf |
|
Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis.
World journal of surgical oncology 2014 12 (1): 71. Zong Liang, Chen Pi |
|
Correlation of imatinib resistance with the mutational status of KIT and PDGFRA genes in gastrointestinal stromal tumors: a meta-analysis.
Journal of gastrointestinal and liver diseases : JGLD 2013 Dec 22 (4): 413-8. Lee Ju-Han, Kim Younghye, Choi Jung-Woo, Kim Young-S |
|
Gastrointestinal stromal tumors in children and young adults: a clinicopathologic and molecular genetic study of 22 Korean cases.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2013 Oct 121 (10): 938-44. Kang Guhyun, Park Young Soo, Jung Eun-Sun, Joo Mee, Kang Mi Seon, Ahn Soomin, Kang Gu Hyum, Kim Kyoung-M |
|
Diagnostic significance of DOG-1 and PKC-? expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
Scandinavian journal of gastroenterology 2013 Sep 48 (9): 1055-65. Wang Chao, Jin Mei-Shan, Zou Ya-Bin, Gao Jing-Na, Li Xiao-Bo, Peng Fang, Wang Hai-Ying, Wu Zhen-Dong, Wang Yin-Ping, Duan Xiu-M |
|
Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study.
The American journal of surgical pathology 2013 Aug 37 (8): 1259-68. Neuville Agnes, Ranchère-Vince Dominique, Dei Tos Angelo Paolo, Montesco Maria Cristina, Hostein Isabelle, Toffolatti Luisa, Chibon Frédéric, Pissaloux Daniel, Alberti Laurent, Decouvelaere Anne-Valérie, Albert Sabrina, Rossi Carlo Riccardo, Blay Jean-Yves, Coindre Jean-Mich |
|
A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del).
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013 Jul 26 (7): 1004-12. Huss Sebastian, Künstlinger Helen, Wardelmann Eva, Kleine Michaela A, Binot Elke, Merkelbach-Bruse Sabine, Rüdiger Thomas, Mittler Jens, Hartmann Wolfgang, Büttner Reinhard, Schildhaus Hans-Ulri |
|
Secondary mutations of c-KIT contribute to acquired resistance to imatinib and decrease efficacy of sunitinib in Chinese patients with gastrointestinal stromal tumors.
Medical oncology (Northwood, London, England) 2013 Jun 30 (2): 522. Gao Jing, Tian Ye, Li Jian, Sun Naiping, Yuan Jiajia, Shen L |
|
Spectrum of mutations in gastrointestinal stromal tumor patients - a population-based study from Slovakia.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2013 Jun 121 (6): 539-48. Minárik Gabriel, Plank Lukáš, Lasabová Zora, Szemes Tomáš, Burjanivová Tatiana, Szépe Peter, Buzalková Veronika, Porubský David, Sufliarsky Joz |
|
Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.
European journal of human genetics : EJHG 2013 May 21 (5): 503-10. Celestino Ricardo, Lima Jorge, Faustino Alexandra, Vinagre João, Máximo Valdemar, Gouveia António, Soares Paula, Lopes José Manu |
|
No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013 May . Lasota J, Xi L, Coates T, Dennis R, Evbuomwan MO, Wang ZF, Raffeld M, Miettinen M |
|
Molecular characterization of an Italian series of sporadic GISTs.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2013 Jan . Origone P, Gargiulo S, Mastracci L, Ballestrero A, Battistuzzi L, Casella C, Comandini D, Cusano R, Dei Tos AP, Fiocca R, Garuti A, Ghiorzo P, Martinuzzi C, Toffolatti L, Bianchi Scarrà G |
|
The KIT Exon 11 Stop Codon Mutation in Gastrointestinal Stromal Tumors: What Is the Clinical Meaning?
Gut and liver 2013 Jan 7 (1): 35-40. Michelucci Angela, Chiappetta Caterina, Cacciotti Jessica, Veccia Norman, Astri Elisa, Leopizzi Martina, Prosperi Porta Romana, Petrozza Vincenzo, Della Rocca Carlo, Bevilacqua Generoso, Cavazzana Andrea, Di Cristofano Claud |
|
Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants.
PloS one 2013 8 (4): e62119. O'Brien Katie M, Orlow Irene, Antonescu Cristina R, Ballman Karla, McCall Linda, DeMatteo Ronald, Engel Lawrence |
|
Gastrointestinal stromal tumors: a case-only analysis of single nucleotide polymorphisms and somatic mutations.
Clinical sarcoma research 2013 3 (1): 12. O'Brien Katie M, Orlow Irene, Antonescu Cristina R, Ballman Karla, McCall Linda, Dematteo Ronald, Engel Lawrence |
|
Practical role of mutation analysis for imatinib treatment in patients with advanced gastrointestinal stromal tumors: a meta-analysis.
PloS one 2013 8 (11): e79275. Zhi Xiaofei, Zhou Xiaoying, Wang Weizhi, Xu Zeku |
|
Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated genotype in gastrointestinal stromal tumors (GISTs).
International journal of clinical and experimental pathology 2013 6 (9): 1839-46. Agaimy Abbas, Otto Claudia, Braun Alexander, Geddert Helene, Schaefer Inga-Marie, Haller Flori |
|
C-KIT mutations were closely associated with the response to Imatinib in Chinese advanced gastrointestinal stromal tumor patients.
Medical oncology (Northwood, London, England) 2012 Dec 29 (5): 3039-45. Gao Jing, Dang Yunzhi, Sun Naiping, Li Jian, Shen L |
|
Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy.
Pharmacological research : the official journal of the Italian Pharmacological Society 2012 Nov . Angelini S, Pantaleo MA, Ravegnini G, Zenesini C, Cavrini G, Nannini M, Fumagalli E, Palassini E, Saponara M, Di Battista M, Casali PG, Hrelia P, Cantelli-Forti G, Biasco G |
|
SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012 Nov . Oudijk L, Gaal J, Korpershoek E, van Nederveen FH, Kelly L, Schiavon G, Verweij J, Mathijssen RH, den Bakker MA, Oldenburg RA, van Loon RL, O'Sullivan MJ, de Krijger RR, Dinjens WN |
|
Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2012 Aug 14 (8): 619-29. Søreide Kjetil, Sandvik Oddvar M, Søreide Jon Arne, Gudlaugsson Einar, Mangseth Kjersti, Haugland Hans Kristi |
|
Multiplex mutation screening by mass spectrometry in gastrointestinal stromal tumours.
Pathology 2012 Jul . Kang G, Lee J, Jang KT, Beadling C, Corless CL, Heinrich MC, Park JO, Kang WK, Park CK, Kim KM |
|
Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study.
Acta oncologica (Stockholm, Sweden) 2012 Apr 51 (4): 528-36. Kang Hye Jin, Ryu Min-Hee, Kim Kyoung-Mee, Park Young Soo, Choi Jene, Ryoo Baek-Yeol, Kim Woo Ho, Im Seock-Ah, Bang Yung-Jue, Park Se Hoon, Lee Jae-Hyuk, Chung Ik Joo, Bae Han-Ik, Kim Jong Gwang, Lee Kyung Hee, Song Hong Suk, Kwon Hyuk-Chan, Baek Jin Ho, Shin Dong Bok, Lee Kyoung Eun, Kang Yoon-K |
|
Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patients.
Investigational new drugs 2012 Apr 30 (2): 819-27. Yoon Dok Hyun, Ryu Min-Hee, Ryoo Baek-Yeol, Beck Moyeol, Choi Dae Ro, Cho Yoojin, Lee Jae-Lyun, Chang Heung-Moon, Kim Tae Won, Kang Yoon-K |
|
KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Mar 18 (6): 1769-76. Miranda Claudia, Nucifora Martina, Molinari Francesca, Conca Elena, Anania Maria Chiara, Bordoni Andrea, Saletti Piercarlo, Mazzucchelli Luca, Pilotti Silvana, Pierotti Marco A, Tamborini Elena, Greco Angela, Frattini Mi |
|
Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012 Feb 23 (2): 353-60. Wozniak A, Rutkowski P, Piskorz A, Ciwoniuk M, Osuch C, Bylina E, Sygut J, Chosia M, Rys J, Urbanczyk K, Kruszewski W, Sowa P, Siedlecki J, Debiec-Rychter M, Limon J, |
|
Synchronous and metachronous multiple gastrointestinal stromal tumors.
Histology and histopathology 2012 Feb 27 (2): 225-34. Xu Chen, Liu Ya-Lan, Yu Hong-Yu, Hou Ying-Yong, Lu Shao-Hua, Zhao Li-Jun, Zhou Yang, Shi Yuan, Tan Yun-Shan, Zhu Xiong-Ze |
|
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.
BMC cancer 2012 12 (1): 107. Rutkowski Piotr, Bylina El?bieta, Klimczak Anna, Switaj Tomasz, Falkowski S?awomir, Kroc Jacek, Lugowska Iwona, Brzeskwiniewicz Magdalena, Melerowicz Wojciech, Osuch Czes?aw, Mierzejewska Ewa, Wasielewski Kacper, Wo?niak Agnieszka, Grzesiakowska Urszula, Nowecki Zbigniew I, Siedlecki Janusz A, Limon Janu |
|
Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Cancer 2011 Nov 117 (21): 4916-24. Rutkowski Piotr, Wozniak Agnieszka, D?biec-Rychter Maria, K?kol Micha?, Dziewirski Wirginiusz, Zdzienicki Marcin, Ptaszynski Konrad, Jurkowska Monika, Limon Janusz, Siedlecki Janusz |
|
Mutational status of KIT and PDGFRA and expression of PDGFRA are not associated with prognosis after curative resection of primary gastrointestinal stromal tumors (GISTs).
Journal of surgical oncology 2011 Jul 104 (1): 59-65. Kern Alexander, Görgens Heike, Dittert Dag-Daniel, Krüger Stefan, Richter Konrad Klaus, Schackert Hans K, Saeger Hans-Detlev, Baretton Gustavo, Pistorius Steff |
|
Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor.
Pathobiology : journal of immunopathology, molecular and cellular biology 2011 78 (3): 132-9. Yamamoto Hidetaka, Kohashi Kenichi, Tsuneyoshi Masazumi, Oda Yoshin |
|
Efficacy evaluation of imatinib treatment in patients with gastrointestinal stromal tumors: a meta-analysis.
World journal of gastroenterology : WJG 2010 Sep 16 (33): 4227-32. Chen Ping, Zong Liang, Zhao Wei, Shi L |
|
Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010 Jul 21 (7): 1552-7. Martin-Broto J, Gutierrez A, Garcia-del-Muro X, Lopez-Guerrero J A, Martinez-Trufero J, de Sande L M, Lainez N, Maurel J, De Juan A, Losa F, Andres R, Casado A, Tejido P G, Blanco R, Carles J, Bellmunt J, Gomez-España A, Ramos R, Martinez-Serra J, Llombart-Bosch A, Poveda |
|
Prognostic relevance of KIT and PDGFRA mutations in gastrointestinal stromal tumors.
Anticancer research 2010 Jun 30 (6): 2407-14. Braggio Esteban, Braggio Danielle De Almeida, Small Isabele Avila, Lopes Lisandro F, Valadão Marcus, Gouveia Maria Emmerick, Moreira Aline Dos Santos, Linhares Eduardo, Romano Sérgio, Bacchi Carlos E, Renault Ilana Zalcberg, Guimarães Denise Peixoto, Ferreira Carlos G |
|
Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010 Feb 21 (2): 208-15. Blay J |
|
Detection of c-KIT and PDGFRA gene mutations in gastrointestinal stromal tumors: comparison of DHPLC and DNA sequencing methods using a single population-based cohort.
American journal of clinical pathology 2010 Jan 133 (1): 149-55. Battochio Angeline, Mohammed Shamayel, Winthrop Debra, Lefresne Shilo, Mulder Karen, Chu Quincy, O'Hara Carolyn, Lai Raymo |
|
Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors.
BMC medicine 2010 8 (1): 26. Silva Mara, Veiga Isabel, Ribeiro Franclim R, Vieira Joana, Pinto Carla, Pinheiro Manuela, Mesquita Bárbara, Santos Catarina, Soares Marta, Dinis José, Santos Lúcio, Lopes Paula, Afonso Mariana, Lopes Carlos, Teixeira Manuel |
|
Homozygous deletion of MTAP gene as a poor prognosticator in gastrointestinal stromal tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Nov 15 (22): 6963-72. Huang Hsuan-Ying, Li Shau-Hsuan, Yu Shih-Chen, Chou Fong-Fu, Tzeng Ching-Cherng, Hu Tsung-Hui, Uen Yih-Huei, Tian Yu-Fang, Wang Yu-Hui, Fang Fu-Min, Huang Wen-Wei, Wei Yu-Ching, Wu Jing-Mei, Li Chien-Fe |
|
Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009 Oct 22 (10): 1351-60. Wei Yu-Ching, Li Chien-Feng, Yu Shih-Chen, Chou Fong-Fu, Fang Fu-Min, Eng Hock-Liew, Uen Yih-Huei, Tian Yu-Fang, Wu Jing-Mei, Li Shau-Hsuan, Huang Wen-Wei, Li Wei-Ming, Huang Hsuan-Yi |
|
Impact of KIT and PDGFRA gene mutations on prognosis of patients with gastrointestinal stromal tumors after complete primary tumor resection.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2009 Sep 13 (9): 1583-92. Hou Ying-Yong, Grabellus Florian, Weber Frank, Zhou Yang, Tan Yun-Shan, Li Jun, Shen Kun-Tang, Qin Jin, Sun Yi-Hong, Qin Xin-Yu, Bockhorn Maximillian, Gerken Guido, Broelsch Christoph E, Frilling Andr |
|
Residual and recurrent gastrointestinal stromal tumors with KIT mutations: findings at first follow-up CT after imatinib treatment.
AJR. American journal of roentgenology 2009 Aug 193 (2): W100-5. Choi Dongil, Yoo Eun Young, Kim Kyoung-Mee, Sohn Tae Sung, Lee Won Jae, Lee Ji Young, Chang Ils |
|
Prognosis and predictive value of KIT exon 11 deletion in GISTs.
British journal of cancer 2009 Jul 101 (1): 1. Bachet JB, Hostein I, Le Cesne A, Brahimi S, Beauchet A, Tabone-Eglinger S, Subra F, Bui B, Duffaud F, Terrier P, Coindre JM, Blay JY, Emile JF |
|
V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.
Journal of clinical pathology 2009 Jul 62 (7): 613-6. Agaimy A, Terracciano L M, Dirnhofer S, Tornillo L, Foerster A, Hartmann A, Bihl M |
|
[Effect of c-kit mutation on the prognosis of gastrointestinal stromal tumors: a meta-analysis].
Zhonghua wai ke za zhi [Chinese journal of surgery] 2009 Jun 47 (11): 857-62. Zhao Wen-Yi, Cao Hui, Zhang Yun, Shen Zhi-Yong, Wu Zhi-Yo |
|
Kinase mutations and efficacy of imatinib in Korean patients with advanced gastrointestinal stromal tumors.
The oncologist 2009 May 14 (5): 540-7. Kim Tae Won, Ryu Min-Hee, Lee Heungnam, Sym Sun Jin, Lee Jae-Lyun, Chang Heung Moon, Park Young Suk, Lee Kyung Hee, Kang Won Ki, Shin Dong Bok, Bang Yung-Jue, Lee Jung Shin, Kang Yoon-K |
|
Spectrum of KIT and PDGFRA mutations in primary gastrointestinal stromal tumors: Polish Clinical GIST Registry experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 May 27 (15_suppl): e21504. Wozniak A, Rutkowski P, Debiec-Rychter M, Siedlecki J, Michej W, Osuch C, Matlok M, Ruka W, Limon J, |
|
Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene.
International journal of clinical oncology 2009 Apr 14 (2): 143-9. Nishida Toshirou, Takahashi Tsuyoshi, Nishitani Akiko, Doi Toshihiko, Shirao Kuniaki, Komatsu Yoshito, Nakajima Kiyokazu, Hirota Seiichi, |
|
A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor.
Oncology 2009 Mar 76 (5): 5. Ryu MH, Kang WK, Bang YJ, Lee KH, Shin DB, Ryoo BY, Roh JK, Kang JH, Lee H, Kim TW, Chang HM, Park JO, Park YS, Kim TY, Kim MK, Lee WK, Kang HJ, Kang YK |
|
Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib.
Pediatric blood & cancer 2009 Mar . Janeway KA, Albritton KH, Van Den Abbeele AD, D'Amato GZ, Pedrazzoli P, Siena S, Picus J, Butrynski JE, Schlemmer M, Heinrich MC, Demetri GD |
|
Pathological characteristics of gastrointestinal stromal tumours with PDGFRA mutations.
Pathology 2009 41 (6): 544-54. Kwon Ji Eun, Kang Hyun Ju, Kim Se Hoon, Lee Yong Chan, Hyung Woo Jin, Noh Sung Hoon, Kim Nam Kyu, Kim Hogu |
|
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Nov 26 (33): 5360-7. Heinrich Michael C, Owzar Kouros, Corless Christopher L, Hollis Donna, Borden Ernest C, Fletcher Christopher D M, Ryan Christopher W, von Mehren Margaret, Blanke Charles D, Rankin Cathryn, Benjamin Robert S, Bramwell Vivien H, Demetri George D, Bertagnolli Monica M, Fletcher Jonathan |
|
Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Nov 26 (33): 5352-9. Heinrich Michael C, Maki Robert G, Corless Christopher L, Antonescu Cristina R, Harlow Amy, Griffith Diana, Town Ajia, McKinley Arin, Ou Wen-Bin, Fletcher Jonathan A, Fletcher Christopher D M, Huang Xin, Cohen Darrel P, Baum Charles M, Demetri George |
|
Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors.
Genes, chromosomes & cancer 2008 Oct 47 (10): 853-9. Agaram Narasimhan P, Wong Grace C, Guo Tianhua, Maki Robert G, Singer Samuel, Dematteo Ronald P, Besmer Peter, Antonescu Cristina |
|
The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
Journal of surgical oncology 2008 Sep 98 (3): 175-8. Du Chun-Yan, Shi Ying-Qiang, Zhou Ye, Fu Hong, Zhao Guang |
|
Spectrum and prognostication of KIT and PDGFRA mutation in gastrointestinal stromal tumors.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2008 May 34 (5): 563-8. Tzen C Y, Wang M N, Mau B |
|
KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008 Apr 19 (4): 706-10. Braconi C, Bracci R, Bearzi I, Bianchi F, Costagliola A, Catalani R, Mandolesi A, Ranaldi R, Galizia E, Cascinu S, Rossi G, Giustini L, Latini L, Valeri N, Cellerino |
|
Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumours.
Histopathology 2007 Sep 51 (3): 379-89. Ryu M H, Kang Y K, Jang S J, Kim T W, Lee H, Kim J S, Park Y H, Lee S S, Ryoo B Y, Chang H M, Lee J L, Yook J H, Kim B S, Lee J |
|
Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
Gastroenterology 2006 May 130 (6): 1573-81. Andersson Johanna, Bümming Per, Meis-Kindblom Jeanne M, Sihto Harri, Nupponen Nina, Joensuu Heikki, Odén Anders, Gustavsson Bengt, Kindblom Lars-Gunnar, Nilsson Ben |
|
Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 Sep 23 (25): 6190-8. Martín Javier, Poveda Andrés, Llombart-Bosch Antonio, Ramos Rafael, López-Guerrero José A, García del Muro Javier, Maurel Joan, Calabuig Silvia, Gutierrez Antonio, González de Sande José L, Martínez Javier, De Juan Ana, Laínez Nuria, Losa Ferrán, Alija Valentín, Escudero Pilar, Casado Antonio, García Paula, García Pilar, Blanco Remei, Buesa José M, |
|
Prognostic value of KIT mutation in gastrointestinal stromal tumors.
World journal of gastroenterology : WJG 2005 Jul 11 (25): 3948-52. Liu Xiao-Hong, Bai Chen-Guang, Xie Qiang, Feng Fei, Xu Zhi-Yun, Ma Da-L |
|
Gastrointestinal stromal tumor: analysis of outcome and correlation with c-kit status in Indian population.
Indian journal of cancer 0 51 (1): 35-9. Cyriac S, Rajendranath R, Sagar T |
|
KIT and PDGFRA mutations and PDGFRA immunostaining in gastrointestinal stromal tumors.
Molecular medicine reports 0 4 (1): 3-8. Barreca Antonella, Fornari Alessandro, Bonello Lisa, Tondat Fabrizio, Chiusa Luigi, Lista Patrizia, Pich Achil |
- Page last reviewed:Mar 1, 2018
- Page last updated:Jul 11, 2019
- Content source: